SINGAPORE - Developer of photonics technologies for medical, industrial, and scientific markets, Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), announced that the United States Patent Office has issued a Notice of Allowance covering the 3D/2D switchable optical imaging system for its glasses-free 3D auto-stereoscopic display system. This Notice of Allowance adds to the other global patents, including U.S. patent number 7,944,465 covering Zecotek’s glasses-free 3D auto-stereoscopic display system, as the Company moves to fully commercialize its innovative 3D technology and other photonics technology.
The United States patent allowance follows the recently announced European and Eurasian patent allowances covering the 3D/2D switchable optical imaging system of Zecotek’s Real-Time 3D Display. The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.
Zecotek’s patented Real-Time 3D Display System is based on the auto-stereoscopic principle, but with substantial innovation. It has the capability of simultaneously presenting to multiple users both 3D and 2D images on the same screen with separate views and at different viewing angles. The 3D display system provides comfortable conditions for viewing a volumetric representation without eye strain. The viewing of such 3D images does not require the use of any supplementary means such as glasses, does not drastically limit the position of the viewer with respect to the display, and allows simultaneous viewing of the 3D display by many viewers from a sufficiently wide field of view.
Patents have now been granted to Zecotek for its 3D display system in the United States, Europe, Russia and Australia. Patents have been filed and are pending in Japan, China, Korea, and India.
-----
Follow us on Twitter and 'like' us on Facebook
Follow OptoIQ on your iPhone; download the free app here.